These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32512047)

  • 21. Reliability, Validity, and Responsiveness of the DEG, a Three-Item Dyspnea Measure.
    Ha DM; Deng LR; Lange AV; Swigris JJ; Bekelman DB
    J Gen Intern Med; 2022 Aug; 37(10):2541-2547. PubMed ID: 34981344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical utility of measures of breathlessness.
    Cullen DL; Rodak B
    Respir Care; 2002 Sep; 47(9):986-93. PubMed ID: 12188932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimal Clinically Important Differences (MCIDs) of the Thai Version of the Leicester Cough Questionnaire for Subacute and Chronic Cough.
    Pornsuriyasak P; Thungtitigul P; Kawamatawong T; Birring SS; Pongmesa T
    Value Health Reg Issues; 2017 May; 12():57-62. PubMed ID: 28648317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Test-retest reliability of multidimensional dyspnea profile recall ratings in the emergency department: a prospective, longitudinal study.
    Parshall MB; Meek PM; Sklar D; Alcock J; Bittner P
    BMC Emerg Med; 2012 May; 12():6. PubMed ID: 22624887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breathlessness, functional status, distress, and palliative care needs over time in patients with advanced chronic obstructive pulmonary disease or lung cancer: a cohort study.
    Weingaertner V; Scheve C; Gerdes V; Schwarz-Eywill M; Prenzel R; Bausewein C; Higginson IJ; Voltz R; Herich L; Simon ST; ;
    J Pain Symptom Manage; 2014 Oct; 48(4):569-81.e1. PubMed ID: 24613784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing health status over time: impact of recall period and anchor question on the minimal clinically important difference of copd health status tools.
    Alma HJ; de Jong C; Jelusic D; Wittmann M; Schuler M; Kollen BJ; Sanderman R; Schultz K; Kocks JWH; Van der Molen T
    Health Qual Life Outcomes; 2018 Jun; 16(1):130. PubMed ID: 29940980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baseline health status and setting impacted minimal clinically important differences in COPD: an exploratory study.
    Alma H; de Jong C; Jelusic D; Wittmann M; Schuler M; Kollen B; Sanderman R; Kocks J; Schultz K; van der Molen T
    J Clin Epidemiol; 2019 Dec; 116():49-61. PubMed ID: 31362055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inspiratory muscle training during pulmonary rehabilitation in chronic obstructive pulmonary disease: A randomized trial.
    Beaumont M; Mialon P; Le Ber-Moy C; Lochon C; Péran L; Pichon R; Gut-Gobert C; Leroyer C; Morelot-Panzini C; Couturaud F
    Chron Respir Dis; 2015 Nov; 12(4):305-12. PubMed ID: 26170421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidimensional Dyspnea Profile: an instrument for clinical and laboratory research.
    Banzett RB; O'Donnell CR; Guilfoyle TE; Parshall MB; Schwartzstein RM; Meek PM; Gracely RH; Lansing RW
    Eur Respir J; 2015 Jun; 45(6):1681-91. PubMed ID: 25792641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of first-recorded breathlessness for future chronic respiratory and heart disease: a cohort study using a UK national primary care database.
    Chen Y; Hayward R; Chew-Graham CA; Hubbard R; Croft P; Sims K; Jordan KP
    Br J Gen Pract; 2020 Apr; 70(693):e264-e273. PubMed ID: 32041768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Individualized breathlessness interventions may improve outcomes in patients with advanced COPD.
    Qian MYY; Politis J; Thompson M; Wong D; Le B; Irving L; Smallwood N
    Respirology; 2018 Dec; 23(12):1146-1151. PubMed ID: 29763515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of the Dyspnea Exertion Scale of Breathlessness in People With Life-Limiting Illness.
    Sandberg J; Johnson MJ; Currow DC; Ekström M
    J Pain Symptom Manage; 2018 Sep; 56(3):430-435.e2. PubMed ID: 29753099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency and characteristics of refractory dyspnea in idiopathic fibrosing interstitial pneumonia.
    Bautin N; Ferlin J; Terce G; Ternynck C; Valentin V; Wemeau L; Chenivesse C
    Respir Med; 2024 Feb; 222():107526. PubMed ID: 38176572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dyspnea-12-Arabic: testing of an instrument to measure breathlessness in Arabic patients with chronic obstructive pulmonary disease.
    Al-Gamal E; Yorke J; Al-Shwaiyat MK
    Heart Lung; 2014; 43(3):244-8. PubMed ID: 24613748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.
    Lenferink A; Brusse-Keizer M; van der Valk PD; Frith PA; Zwerink M; Monninkhof EM; van der Palen J; Effing TW
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011682. PubMed ID: 28777450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinically important differences in the intensity of chronic refractory breathlessness.
    Johnson MJ; Bland JM; Oxberry SG; Abernethy AP; Currow DC
    J Pain Symptom Manage; 2013 Dec; 46(6):957-63. PubMed ID: 23608121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of overestimation or underestimation of the functional capacity using MRC score as compared to 6-minute walk test in patients with cardio-respiratory disorders.
    Callens E; Graba S; Essalhi M; Gillet-Juvin K; Chevalier-Bidaud B; Chenu R; Mahut B; Delclaux C
    COPD; 2014 Sep; 11(5):496-502. PubMed ID: 24832477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bridging the gap: using triangulation methodology to estimate minimal clinically important differences (MCIDs).
    Leidy NK; Wyrwich KW
    COPD; 2005 Mar; 2(1):157-65. PubMed ID: 17136977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The MCID of the transition dyspnea index is a total score of one unit.
    Mahler DA; Witek TJ
    COPD; 2005 Mar; 2(1):99-103. PubMed ID: 17136969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.